Testing biotech Ellume fronts up seeking $500m-plus valuation
SYDNEY: Investors are getting up close and personal with rapid diagnostics company Ellume, a Queensland-based
SYDNEY: Investors are getting up close and personal with rapid diagnostics company Ellume, a Queensland-based